AI Science Tracker
EN

Department of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China

1 discovery from 2024

Discoveries

Development and validation of a machine learning-based 18 F-fluorodeoxyglucose PET/CT radiomics signature for predicting gastric cancer survival.

Source check: Source checked. Not independent scientific confirmation.

Finding: Internal cohort evaluation measured treatment-response discrimination; no prospective clinical benefit or independent external validation was established. The finding is bounded to the reported study and does not establish causal benefit or generalization.

Technology: PET radiomics and machine-learning classifier predict treatment response in the reported clinical cohort

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
PET radiomics and machine-learning classifier predict treatment response in the reported clinical cohort
Test and result
Internal cohort evaluation measured treatment-response discrimination; no prospective clinical benefit or independent external validation was established.
Limitation / still unknown
External validation, causal effects, and sustained operational impact were not established in the reviewed material.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11290137/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.